Pathology Hiding in Plain Sight: The NF1 Plasma Membrane
DOI:
https://doi.org/10.17140/CSMMOJ-6-e008Abstract
The passive voice and the active voice: for example, is it a matter of “at” or “to?” The NF1 gene product, neurofibromin (Nfn), in its interaction with the oncoprotein, Ras, does something to the cell’s plasma membrane (PM); the reactions in question do not merely happen at the cell’s PM. Moreover, what the Nfn does to the PM in NF1 cells has been seriously underestimated because of yet another perspective issue. The vast majority of publications on the membrane-bound interaction of Nfn and Ras have been from the perspective that, first and foremost – if not exclusively – the NF1 gene is considered a “tumor suppressor gene.” This is rather narrow, respecting the ancient origin and very highly conserved nature of the NF1 alphabetical code, and the intuitive understanding that the vast majority of eukaryotic species are not at risk for tumors or cancer.
References
Bloomfield G, Traynor D, Sander SP, Veltman DM, Pache-bat JA, Kay RR. Neurofibromin controls macropinocytosis and phagocytosis in Dictyostelium. eLIFE. 2015; 4. doi: 10.7554/ eLife.04940
Zhang S, Charest PG, Firtel RA. Spatiotemporal regulation of Ras activity provides directional sensing. Curr Biol. 2008; 18: 1587- 1593. doi: 10.1016/j.cub.2008.08.069
Wagner GP. Homology, Genes and Evolutionary Innovation. Princ-eton, NJ, USA: Princeton University Press; 2014.
Leevers SJ, Paterson HF, Marshall CJ. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma mem-brane. Nature. 1994; 369: 411-414. doi: 10.1038/369411a0
Moodie SA, Willumsen BM, Weber MJ, Wolfman A. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase ki-nase. Science. 1993; 260: 1658-1661. doi: 10.1126/science.8503013
Moodie SA, Paris M, Villafranca E, Kirshmeier P, Willumsen BM, Wolfman A. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets. Oncogene. 1995; 11: 447-454.
Marshall M. Interactions between Ras and Raf: key regulatory proteins in cellular transformation. Mol Reprod Dev. 1995; 42: 493- 499. doi: 10.1002/mrd.1080420418
McClatchey AI, Cichowski K. SPRED proteins provide a NF-ty link to Ras suppression. Genes Dev. 2012; 26: 1515-1519. doi: 10.1101/gad.197434.112
Hirata Y, Brems H, Suzuki M, et al. Interaction between a do-main of the negative regulator of the Ras-ERK pathway, SPRED1 protein, and the GTPase-activating protein-related domain of neurofibromin is implicated in legius syndrome and neurofibro-matosis type 1. J Biol Chem. 2016; 291: 3124-3134. doi: 10.1074/ jbc.M115.703710 Editorial | Volume 6 | Number 1| Cancer Stud Mol Med Open J. 2020; 6(1): e1-e3. doi: 10.17140/CSMMOJ-6-e008
Sondermann H, Soisson SM, Boykevisch S, Yang SS, Bar-Sagi D, Kuriyan J. Structural analysis of autoinhibition in the Ras ac-tivator son of sevenless. Cell. 2004; 119: 393-405. doi: 10.1016/j. cell.2004.10.005
Jimbow K, Horikoshi T. The nature and significance of macromelanosomes in pigmented skin lesions: Their morpholog-ical characteristics, specificity for their occurrence, and possible mechanisms for their formation. Am J Dermatopathol. 1982; 4: 413- Submit your article to this journal | https://openventio.org/submit-manuscript/ Editorial | Volume 6 | Number 1| Riccardi VM 420. doi: 10.1097/00000372-198210000-00006
Martuza RL, Phillippe I, Fitzpatrick TB, Zwaan J, Seki Y, Lederman J. Melanin macroglobules as a cellular marker of neu-rofibromatosis: A quantitative study. J Invest Dermatol. 1985; 85: 347-350. doi: 10.1111/1523-1747.ep12276952
Nakagawa H, Hori Y, Sato S, Fitzpatrick TB, Martuza RL. The nature and origin of the melanin macroglobule. J Invest Dermatol. 1984; 83: 134-139. doi: 10.1111/1523-1747.ep12263325 e3
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Cancer Studies and Molecular Medicine (CSMM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
